menu
    • menu

    Company profile for HANDOK

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Handok grew as a joint venture with Hoechst/Aventis/Sanofi from 1964 to 2012. Handok has also established strategic collaborations in several areas with multiple multinational pharmaceutical companies. Handok ended its joint venture relationship with Sanofi in 2012 and became an independent company again. Handok changed its company name from Handok Pharmaceutical Co., Ltd to Handok Inc. and declared its vision to become “The...
    Handok grew as a joint venture with Hoechst/Aventis/Sanofi from 1964 to 2012. Handok has also established strategic collaborations in several areas with multiple multinational pharmaceutical companies. Handok ended its joint venture relationship with Sanofi in 2012 and became an independent company again. Handok changed its company name from Handok Pharmaceutical Co., Ltd to Handok Inc. and declared its vision to become “The Health Innovator” and as Korea’s leading global healthcare company. Handok introduces new products to the Korean market through partnerships, internal R&D, and state-of-the-art manufacturing.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    HANDOKkorearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    132, Teheran-ro, Gangnam-gu, Seoul, 06235
    Telephone
    Telephone
    82-2-527-5114
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.handok.co.kr/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/handok
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biocon inks licensing, supply pact Handok for chronic weight management product
    Biocon inks licensing, supply pact Handok for chronic weight management product

    24 May 2024

    // PRESS RELEASE

    https://www.biocon.com/biocon-limited-signs-exclusive-licensing-and-supply-deal-for-the-commercialization-of-liraglutide-in-south-korea-with-handok-inc/

    PRESS RELEASE
    24 May 2024
    Share Share
    AUM Biosciences and HANDOK Presented Phase 1 Data for AUM-601 at ESMO
    AUM Biosciences and HANDOK Presented Phase 1 Data for AUM-601 at ESMO

    19 Apr 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/04/19/2424383/0/en/AUM-Biosciences-and-HANDOK-Presented-Phase-1-Data-for-AUM-601-at-ESMO-Targeted-Anticancer-Therapies-Congress-2022.html

    GLOBENEWSWIRE
    19 Apr 2022
    Share Share
    Handok scores FDA nod to test anticancer drug in phase 2 trial
    Handok scores FDA nod to test anticancer drug in phase 2 trial

    24 Jan 2022

    // Kim Yun-mi KOREABIOMED

    http://www.koreabiomed.com/news/articleView.html?idxno=13003

    Kim Yun-mi KOREABIOMED
    24 Jan 2022
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search